AD Toolbox Part 1: Pathophysiology and Burden of AD
Drs. Larry Eichenfield and Eric Simpson discuss the pathophysiology and burden of atopic dermatitis, including skin barrier dysfunction, abnormal immune activation, epidemiology, comorbidities, and the overall affect on everyday life for AD patients and their families. About the AD Video Series This is the first video in a comprehensive atomic dermatitis educational series designed for NPs […]
LITERATURE LESSONS
Covid-19 Seven hundred and forty patients, mean age 49 and drawn from the Mount Sinai Health System, were tested with an extensive battery of validated neuropsychological tests at an average 7.6 months following their acute COVID-19 infection. Eleven percent to 24% were found to have defects in various domains of COGNITIVE FUNCTION, with more individuals […]
Off-label Pearl
By Ted Rosen, MD, FAAD, Editor-in-Chief Acitretin for blockade-induced psoriasis Immune checkpoint inhibitors (anti-PD-1 drugs) restore the anti-tumor actions of T-cells. However, by decreasing T-cell inhibition, these agents may then provoke a number of autoimmune disorders, including a worsening or induction of psoriasis. Stopping the immune checkpoint drug may be problematic, as treatment options may […]